AI Dock Raises ¥260 Million to Transform Preventive Medicine with AI-Enhanced Full-Body Scans
Funding Overview
AI Dock Inc. has announced the successful completion of a seed funding round, raising approximately 260 million yen. This round includes participation from MRSO Inc., the operator of Japan’s largest comprehensive medical checkup booking site, along with a group of prominent medical experts and entrepreneurs. The newly secured capital will be allocated toward product development, expanding the network of partner medical institutions, enhancing brand identity and customer experience, and strengthening the service delivery structure through the recruitment of specialized talent.
About AI Dock Inc.
AI Dock was established as the inaugural project of Bio Engineering Capital’s company creation initiative (formerly operating as Med X Inc.). With medical supervision from Dr. Taro Takahara—the inventor of the DWIBS (Diffusion-weighted Whole-body Imaging with Background Body Signal suppression) method—the company provides a preventive healthcare service that integrates diagnostic imaging, blood tests, and lifestyle data. Operating under the core philosophy that "true value begins after the exam," AI Dock aims to implement a data-driven, continuous health management system into the fabric of society.
Strategic Objectives and Future Outlook
Moving forward, AI Dock will accelerate its efforts to improve service quality and expand its clinical partnerships. In collaboration with MRSO and other strategic partners, the company will also focus on verifying the effectiveness of its solutions within corporate wellness programs and enterprise-level deployments. Furthermore, AI Dock plans to refine the "post-exam" experience through the development of narrative reports and personalized AI, building a platform that bridges the gap between clinical medicine and daily lifestyle.
List of Participating Investors
Key investors in this round include (in no particular order):
- MRSO Inc. (Strategic Partner)
- Takeshi Ide, M.D., Ph.D. (Director, Tokyo Vision Eye Clinic Asagaya)
- Kentaro Ogata (Founder & CEO, Voicy Inc.)
- Michihito Sugawara (Neurosurgeon / Chairman, Akasaka Park Building Neurosurgery)
- Kunihiro Tanaka (Founder & CEO, Sakura Internet Inc.)
- Shigeki Kijima (Diagnostic Radiologist / Representative, TRN LLC)
- Yuki Higuchi (Managing Partner, Deep Growth Capital)
- Matěj Chmelo (Investor)